II. Indications
- Acute Migraine Headache
- Third-line agent in acute Migraine Headaches refractory to NSAIDS and Triptans
- Avoid for acute Migraines if also using Injectable CGRP Inhibitor for Migraine Prophylaxis
- Avoid using in combination with Triptans (no evidence of benefit)
-
Migraine Prophylaxis
- Rimegepant (Nurtec) is FDA approved for Migraine Prophylaxis in 2021 (third-line agent)
- Injectable CGRP Inhibitors are also indicated in Migraine Prophylaxis
III. Mechanism
-
Calcitonin
Gene-Related Peptide (CGRP)
- CGRP is a neuropeptide that acts as a vasodilator and pain sensitization
- CGRP Is released by trigeminal Neurons in Migraine Headache, Cluster Headache and Trigeminal Neuralgia
- CGRP Inhibitors block CalcitoninGene-Related Peptide (CGRP)
- Gepants are oral or intranasal agents that block CGRP
- Contrast with CGRP Monoclonal Antibody agents that are injectable
IV. Preparations
- Ubrogepant (Ubrelvy)
- Dose: 50 to 100 mg orally with or without food
- May repeat a second dose 2 hours after first)
- Maximum: 200 mg/24 hours
- Costs $85 per tablet (contrast with 70 cents per Sumatriptan tablet)
- May be repeated 2 hours after first dose if inadequate effect
- Resources: DailyMed
- Dose: 50 to 100 mg orally with or without food
- Rimegepant (Nurtec)
- Migraine Abortive Treatment
- Dissolving oral tablet: 75 mg taken as single dose (maximum 75 mg/day)
- Migraine Prophylaxis
- Dissolving oral tablet: 75 mg taken every OTHER day (maximum 18 days per month)
- Breakthrough acute Migraine Headache should not be treated with Rimegepant
- Use another type of Migraine Abortive Treatment
- Cost: $1800/month (contrast with $630/month for Injectable CGRP Inhibitors)
- Resources: DailyMed
- Migraine Abortive Treatment
- Zavegepant (Zavzpret)
- Intranasal Gepant (useful when Nausea, Vomiting interferes with taking medication)
- Migraine Abortive Treatment Dosing
- One spray (10 mg/spray) intranasal per 24 hours as needed
- Pharmacokinetics
- Onset: 15 minutes
- Peak: 30 minutes
- Half-Life: 6.5 hours
- Adverse Effects
- Safety
- Has not been studied in pregnancy, children, liver or renal Impairment
- References
- Atogepant (Qulipta)
- Migraine Prophylaxis
- Start 10 mg orally daily (maximum dose 60 mg/day)
- Adjust dose for CYP3A4 inhibitors and inducers, as well as OATP Inhibitors
- Resources: DailyMed
- Migraine Prophylaxis
V. Efficacy
-
Migraine Abortive Treatment (less effective than Triptans)
- NNT 10 for one patient to be pain free at 2 hours
- Contrast with the more effective and less expensive Triptans
- Sumatriptan NNT 5
- Cost of Gepants (>$100/dose) in 2024 is as much as 100 fold more than Triptans
-
Migraine Prophylaxis
- Rimegepant prevents 1 Migraine more than Placebo per month in those with 10 Migraines/month on average
- Similar efficacy to other Migraine Prophylaxis agents including Injectable CGRP Inhibitors
VI. Adverse Effects
VII. Drug Interactions
VIII. References
- (2024) Presc Lett 31(2): 9-10
- (2020) Presc Lett 27(3): 13
- (2021) Presc Lett 28(8): 43-4
- LoVecchio (2020) Crit Dec Emerg Med 34(2):28
- LoVecchio (2023) Crit Dec Emerg Med 37(5):32
Images: Related links to external sites (from Bing)
Related Studies
ubrelvy (on 1/14/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
UBRELVY 100 MG TABLET | $90.07 each | |
UBRELVY 50 MG TABLET | $89.78 each | |
nurtec (on 1/17/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
NURTEC ODT 75 MG TABLET | $110.19 each | |
zavzpret (on 10/18/2023 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
ZAVZPRET 10 MG NASAL SPRAY | $175.94 each | |
qulipta (on 2/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
QULIPTA 10 MG TABLET | $31.82 each | |
QULIPTA 30 MG TABLET | $31.52 each | |
QULIPTA 60 MG TABLET | $31.83 each |